Skip to content
Therapy But Better – Lifestyle
Author:
Pasithea
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
June 15, 2026
Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
June 2, 2026
←
Previous Page
1
2